HERON THERAPEUTICS, INC. /DE/ (HRTX) AI Dilution Summary

Heron's estimated cash was $27,578,390 as of 2026-08-07. That figure is rolled forward from $42,664,000 at the 2026-06-30 balance-sheet date, against estimated monthly burn of $737,667. On 2026-08-07 the company made a $13,500,000 principal prepayment and paid a $661,500 end-of-term fee under the Hercules facility amendment.